ZA857721B - Process for treatment of rheumatic diseases - Google Patents

Process for treatment of rheumatic diseases

Info

Publication number
ZA857721B
ZA857721B ZA857721A ZA857721A ZA857721B ZA 857721 B ZA857721 B ZA 857721B ZA 857721 A ZA857721 A ZA 857721A ZA 857721 A ZA857721 A ZA 857721A ZA 857721 B ZA857721 B ZA 857721B
Authority
ZA
South Africa
Prior art keywords
treatment
rheumatic diseases
rheumatic
diseases
preparations
Prior art date
Application number
ZA857721A
Other languages
English (en)
Inventor
Johann-Friedrich Von Eichborn
Hans-Joachim Obert
Franz Link
Original Assignee
Bioferon Biochem Substanz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6247225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA857721(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioferon Biochem Substanz filed Critical Bioferon Biochem Substanz
Publication of ZA857721B publication Critical patent/ZA857721B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA857721A 1984-10-05 1985-10-07 Process for treatment of rheumatic diseases ZA857721B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3436638A DE3436638C2 (de) 1984-10-05 1984-10-05 Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen

Publications (1)

Publication Number Publication Date
ZA857721B true ZA857721B (en) 1986-09-24

Family

ID=6247225

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA857721A ZA857721B (en) 1984-10-05 1985-10-07 Process for treatment of rheumatic diseases

Country Status (5)

Country Link
EP (1) EP0180737B1 (enExample)
JP (1) JPS6191135A (enExample)
AT (1) ATE45675T1 (enExample)
DE (2) DE3436638C2 (enExample)
ZA (1) ZA857721B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders
DE4238159A1 (en) * 1992-11-12 1993-04-29 Josef Dr Med Mueller Treatment of prim. chronic polyarthritis and diabetes mellitus - comprises administration of gamma-interferon
JP2850293B2 (ja) * 1996-10-25 1999-01-27 株式会社林原生物化学研究所 γ−インターフェロン感受性疾患剤
US6299871B1 (en) * 1998-07-24 2001-10-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527168A (en) * 1978-04-11 1980-02-27 Verronmay Ltd Drug composition
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
EP0305551A3 (en) * 1981-10-13 1990-01-10 Exovir, Inc. Pharmaceutical compositions for topical application
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
US4483849A (en) * 1983-01-07 1984-11-20 Carter William A Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
JP3108538B2 (ja) * 1992-08-13 2000-11-13 松下電工株式会社 平面トランス

Also Published As

Publication number Publication date
ATE45675T1 (de) 1989-09-15
EP0180737A2 (de) 1986-05-14
EP0180737A3 (en) 1986-05-28
DE3436638C2 (de) 1992-10-08
DE3436638A1 (de) 1986-04-17
EP0180737B1 (de) 1989-08-23
JPS6191135A (ja) 1986-05-09
JPH0544930B2 (enExample) 1993-07-07
DE3572441D1 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
GB2175805B (en) Treatment of oral diseases.
EP0151910A3 (en) Radiotherapy treatment table
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
ZA887889B (en) Process for the manufacture of 1,1,1-trifluorodichloroethylene and 1,1,1,2-tetrafluorochloroethylene
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
JO1438B1 (en) Therapeutic agents
JO1482B1 (en) Therapeutic agents
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
HUT43111A (en) Process for producing human lizozime
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
DE3466539D1 (en) 4'-flavonecarboxylic acids, process for their preparation and their therapeutical use
ZA857721B (en) Process for treatment of rheumatic diseases
JO1483B1 (en) Therapeutic agents
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
GB2098478B (en) Propioibacteria preparations for use in the treatment of tumours
ZA884262B (en) Pharmaceutical composition for the treatment of tumors
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
EP0215200A3 (en) Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases
GR3005231T3 (enExample)
EP0245368A4 (en) TREATMENT OF DEMYELINIZATION DISEASES.
AU581027C (en) Process for treatment of rheumatic diseases using gamma interferon
EP0344820A3 (en) Means for the treatment of cardiac diseases
GR3002328T3 (en) 2-(benzhydrylsulfonyl) acetamide, process for its preparation and its therapeutical use
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
DE3373907D1 (en) N-acyl derivatives of dipeptides, their manufacture and use in treating diseases, and means therefor